Revenue
Cost
Profit
| Item | Category | Value | YoY |
|---|---|---|---|
| Net sales | revenue | 11.16B | 7.78% |
| Other nonoperating income (expense) | revenue | 159.00M | 25.20% |
| Investment income, interest | revenue | 106.00M | 29.27% |
| Gain (loss), foreign currency transaction, before tax | revenue | 13.00M | 85.71% |
| Operating earnings | profit | 1.34B | -20.56% |
| Total operating cost and expenses | cost | 9.82B | 13.32% |
| Aggregate | revenue | 1.62B | -14.98% |
| Cost of products sold, excluding amortization of intangible assets | cost | 4.89B | 9.44% |
| Selling, general, and administrative | cost | 3.74B | 22.18% |
| Research and development | cost | 767.00M | 7.12% |
| Amortization of intangible assets | cost | 422.00M | 0.48% |
| Earnings before taxes | profit | 1.45B | -18.50% |
| Interest expense | cost | 174.00M | 32.82% |
| Net earnings | profit | 1.08B | -18.72% |
| Taxes on earnings | cost | 372.00M | -17.88% |
| Segment | Value | YoY |
|---|---|---|
| Medical Devices | 5.54B | 13.16% |
| Diagnostic Products | 2.18B | 6.13% |
| Nutritional Products | 2.02B | -6.01% |
| Established Pharmaceutical Products | 1.43B | 13.17% |
| Others | 2.00M | -33.33% |
| Segment | Value | YoY |
|---|---|---|
| Non-US | 6.89B | 11.31% |
| UNITED STATES | 4.27B | 2.54% |
| Item | Category | Value | YoY |
|---|---|---|---|
| Finished products | assets | 4.27B | |
| Materials | assets | 1.72B | |
| Work in process | assets | 994.00M | |
| Total inventories | assets | 6.99B | |
| Property and equipment, at cost | assets | 25.74B | |
| Accounts receivable, after allowance for credit loss, current | assets | 8.21B | |
| Cash and cash equivalents | assets | 6.80B | |
| Prepaid expense and other receivables | assets | 3.01B | |
| Short-term investments | assets | 492.00M | |
| Total current assets | assets | 25.51B | |
| Less: accumulated depreciation and amortization | assets | 13.36B | |
| Net property and equipment | assets | 12.38B | |
| Goodwill, non-deductible | assets | 35.22B | |
| Deferred income taxes and other assets | assets | 18.36B | |
| Intangible assets, net of amortization | assets | 17.88B | |
| Investments | assets | 1.09B | |
| Total assets | assets | 110.43B | |
| Total shareholders’ investment | liabilities | 52.70B | |
| Long-term debt | liabilities | 29.64B | |
| Total current liabilities | liabilities | 18.38B | |
| Post-employment obligations, deferred income taxes and other long-term liabilities | liabilities | 9.71B | |
| Equity, attributable to noncontrolling interest | liabilities | 640.00M | |
| Treasury stock, common, value | equity | 16.93B | |
| Accumulated other comprehensive income (loss) | equity | 6.31B | |
| Total abbott shareholders’ investment | equity | 52.06B | |
| Other accrued liabilities | liabilities | 6.38B | |
| Trade accounts payable | liabilities | 4.68B | |
| Current portion of long-term debt | liabilities | 4.41B | |
| Salaries, wages, and commissions | liabilities | 1.21B | |
| Dividends payable | liabilities | 1.10B | |
| Accrued income taxes, current | liabilities | 598.00M | |
| Aggregate | equity | 75.31B | |
| Earnings employed in the business | equity | 49.96B | |
| Common stock, value, issued | equity | 25.35B |
| Item | Value |
|---|---|
| Net earnings | 1.08B |
| Amortization of intangible assets | 422.00M |
| Depreciation | 381.00M |
| Share-based compensation | 317.00M |
| Increase (decrease) in accounts receivable | -42.00M |
| Increase (decrease) in inventories | -420.00M |
| Increase (decrease) in other operating assets and liabilities, net | -420.00M |
| Item | Value |
|---|---|
| Payment for (proceeds from) other investing activity | 34.00M |
| Payments for (proceeds from) investments | -161.00M |
| Payments to acquire property, plant, and equipment | -399.00M |
| Payments to acquire businesses, net of cash acquired, and research and development in process | -19.80B |
| Item | Value |
|---|---|
| Proceeds from issuance of long-term debt | 19.86B |
| Proceeds from stock options exercised | 116.00M |
| Proceeds from (repayments of) short-term debt | 31.00M |
| Payments for repurchase of common stock | -180.00M |
| Payments of ordinary dividends, common stock | -1.10B |
| Repayments of long-term debt | -1.42B |
| Item | Value |
|---|---|
| Cash and cash equivalents, beginning of period | 8.52B |
| Cash and cash equivalents, end of period | 6.80B |
Instantly decode complex 10-K and 10-Q data. Explore interactive Sankey diagrams for income and balance sheets, and intuitive waterfall charts for cash flows.
Search for a company and select a report on the left panel.
Request Stock Support